[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Avanafil Market Insights, Forecast to 2029

November 2023 | 90 pages | ID: G6759F2E13DEEN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Avanafil, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Avanafil, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Avanafil, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Avanafil sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Avanafil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Avanafil sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including VIVUS Inc, Sanofi, Menarini Group, Auxilium Pharmaceuticals, Endo International and JW Pharmaceutical, etc.

By Company
  • VIVUS Inc
  • Sanofi
  • Menarini Group
  • Auxilium Pharmaceuticals
  • Endo International
  • JW Pharmaceutical
Segment by Type
  • 50 mg Avanafil
  • 100 mg Avanafil
  • 200 mg Avanafil
Segment by Application
  • The Young Man
  • Middle-Aged Person
  • Others
Segment by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Avanafil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Avanafil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avanafil sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Avanafil Product Introduction
1.2 Market by Type
  1.2.1 Global Avanafil Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 50 mg Avanafil
  1.2.3 100 mg Avanafil
  1.2.4 200 mg Avanafil
1.3 Market by Application
  1.3.1 Global Avanafil Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 The Young Man
  1.3.3 Middle-Aged Person
  1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Avanafil Sales Estimates and Forecasts 2018-2029
2.2 Global Avanafil Revenue by Region
  2.2.1 Global Avanafil Revenue by Region: 2018 VS 2022 VS 2029
  2.2.2 Global Avanafil Revenue by Region (2018-2023)
  2.2.3 Global Avanafil Revenue by Region (2024-2029)
  2.2.4 Global Avanafil Revenue Market Share by Region (2018-2029)
2.3 Global Avanafil Sales Estimates and Forecasts 2018-2029
2.4 Global Avanafil Sales by Region
  2.4.1 Global Avanafil Sales by Region: 2018 VS 2022 VS 2029
  2.4.2 Global Avanafil Sales by Region (2018-2023)
  2.4.3 Global Avanafil Sales by Region (2024-2029)
  2.4.4 Global Avanafil Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURES

3.1 Global Avanafil Sales by Manufacturers
  3.1.1 Global Avanafil Sales by Manufacturers (2018-2023)
  3.1.2 Global Avanafil Sales Market Share by Manufacturers (2018-2023)
  3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Avanafil in 2022
3.2 Global Avanafil Revenue by Manufacturers
  3.2.1 Global Avanafil Revenue by Manufacturers (2018-2023)
  3.2.2 Global Avanafil Revenue Market Share by Manufacturers (2018-2023)
  3.2.3 Global Top 10 and Top 5 Companies by Avanafil Revenue in 2022
3.3 Global Key Players of Avanafil, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Avanafil Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
  3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  3.5.2 Global Avanafil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Avanafil, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Avanafil, Product Offered and Application
3.8 Global Key Manufacturers of Avanafil, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Avanafil Sales by Type
  4.1.1 Global Avanafil Historical Sales by Type (2018-2023)
  4.1.2 Global Avanafil Forecasted Sales by Type (2024-2029)
  4.1.3 Global Avanafil Sales Market Share by Type (2018-2029)
4.2 Global Avanafil Revenue by Type
  4.2.1 Global Avanafil Historical Revenue by Type (2018-2023)
  4.2.2 Global Avanafil Forecasted Revenue by Type (2024-2029)
  4.2.3 Global Avanafil Revenue Market Share by Type (2018-2029)
4.3 Global Avanafil Price by Type
  4.3.1 Global Avanafil Price by Type (2018-2023)
  4.3.2 Global Avanafil Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

5.1 Global Avanafil Sales by Application
  5.1.1 Global Avanafil Historical Sales by Application (2018-2023)
  5.1.2 Global Avanafil Forecasted Sales by Application (2024-2029)
  5.1.3 Global Avanafil Sales Market Share by Application (2018-2029)
5.2 Global Avanafil Revenue by Application
  5.2.1 Global Avanafil Historical Revenue by Application (2018-2023)
  5.2.2 Global Avanafil Forecasted Revenue by Application (2024-2029)
  5.2.3 Global Avanafil Revenue Market Share by Application (2018-2029)
5.3 Global Avanafil Price by Application
  5.3.1 Global Avanafil Price by Application (2018-2023)
  5.3.2 Global Avanafil Price Forecast by Application (2024-2029)

6 US & CANADA

6.1 US & Canada Avanafil Market Size by Type
  6.1.1 US & Canada Avanafil Sales by Type (2018-2029)
  6.1.2 US & Canada Avanafil Revenue by Type (2018-2029)
6.2 US & Canada Avanafil Market Size by Application
  6.2.1 US & Canada Avanafil Sales by Application (2018-2029)
  6.2.2 US & Canada Avanafil Revenue by Application (2018-2029)
6.3 US & Canada Avanafil Market Size by Country
  6.3.1 US & Canada Avanafil Revenue by Country: 2018 VS 2022 VS 2029
  6.3.2 US & Canada Avanafil Sales by Country (2018-2029)
  6.3.3 US & Canada Avanafil Revenue by Country (2018-2029)
  6.3.4 US
  6.3.5 Canada

7 EUROPE

7.1 Europe Avanafil Market Size by Type
  7.1.1 Europe Avanafil Sales by Type (2018-2029)
  7.1.2 Europe Avanafil Revenue by Type (2018-2029)
7.2 Europe Avanafil Market Size by Application
  7.2.1 Europe Avanafil Sales by Application (2018-2029)
  7.2.2 Europe Avanafil Revenue by Application (2018-2029)
7.3 Europe Avanafil Market Size by Country
  7.3.1 Europe Avanafil Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 Europe Avanafil Sales by Country (2018-2029)
  7.3.3 Europe Avanafil Revenue by Country (2018-2029)
  7.3.4 Germany
  7.3.5 France
  7.3.6 U.K.
  7.3.7 Italy
  7.3.8 Russia

8 CHINA

8.1 China Avanafil Market Size
  8.1.1 China Avanafil Sales (2018-2029)
  8.1.2 China Avanafil Revenue (2018-2029)
8.2 China Avanafil Market Size by Application
  8.2.1 China Avanafil Sales by Application (2018-2029)
  8.2.2 China Avanafil Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Avanafil Market Size by Type
  9.1.1 Asia Avanafil Sales by Type (2018-2029)
  9.1.2 Asia Avanafil Revenue by Type (2018-2029)
9.2 Asia Avanafil Market Size by Application
  9.2.1 Asia Avanafil Sales by Application (2018-2029)
  9.2.2 Asia Avanafil Revenue by Application (2018-2029)
9.3 Asia Avanafil Sales by Region
  9.3.1 Asia Avanafil Revenue by Region: 2018 VS 2022 VS 2029
  9.3.2 Asia Avanafil Revenue by Region (2018-2029)
  9.3.3 Asia Avanafil Sales by Region (2018-2029)
  9.3.4 Japan
  9.3.5 South Korea
  9.3.6 China Taiwan
  9.3.7 Southeast Asia
  9.3.8 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Avanafil Market Size by Type
  10.1.1 Middle East, Africa and Latin America Avanafil Sales by Type (2018-2029)
  10.1.2 Middle East, Africa and Latin America Avanafil Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Avanafil Market Size by Application
  10.2.1 Middle East, Africa and Latin America Avanafil Sales by Application (2018-2029)
  10.2.2 Middle East, Africa and Latin America Avanafil Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Avanafil Sales by Country
  10.3.1 Middle East, Africa and Latin America Avanafil Revenue by Country: 2018 VS 2022 VS 2029
  10.3.2 Middle East, Africa and Latin America Avanafil Revenue by Country (2018-2029)
  10.3.3 Middle East, Africa and Latin America Avanafil Sales by Country (2018-2029)
  10.3.4 Brazil
  10.3.5 Mexico
  10.3.6 Turkey
  10.3.7 Israel
  10.3.8 GCC Countries

11 COMPANY PROFILES

11.1 VIVUS Inc
  11.1.1 VIVUS Inc Company Information
  11.1.2 VIVUS Inc Overview
  11.1.3 VIVUS Inc Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.1.4 VIVUS Inc Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.1.5 VIVUS Inc Recent Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Overview
  11.2.3 Sanofi Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.2.4 Sanofi Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.2.5 Sanofi Recent Developments
11.3 Menarini Group
  11.3.1 Menarini Group Company Information
  11.3.2 Menarini Group Overview
  11.3.3 Menarini Group Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.3.4 Menarini Group Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.3.5 Menarini Group Recent Developments
11.4 Auxilium Pharmaceuticals
  11.4.1 Auxilium Pharmaceuticals Company Information
  11.4.2 Auxilium Pharmaceuticals Overview
  11.4.3 Auxilium Pharmaceuticals Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.4.4 Auxilium Pharmaceuticals Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.4.5 Auxilium Pharmaceuticals Recent Developments
11.5 Endo International
  11.5.1 Endo International Company Information
  11.5.2 Endo International Overview
  11.5.3 Endo International Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.5.4 Endo International Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.5.5 Endo International Recent Developments
11.6 JW Pharmaceutical
  11.6.1 JW Pharmaceutical Company Information
  11.6.2 JW Pharmaceutical Overview
  11.6.3 JW Pharmaceutical Avanafil Sales, Price, Revenue and Gross Margin (2018-2023)
  11.6.4 JW Pharmaceutical Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
  11.6.5 JW Pharmaceutical Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Avanafil Industry Chain Analysis
12.2 Avanafil Key Raw Materials
  12.2.1 Key Raw Materials
  12.2.2 Raw Materials Key Suppliers
12.3 Avanafil Production Mode & Process
12.4 Avanafil Sales and Marketing
  12.4.1 Avanafil Sales Channels
  12.4.2 Avanafil Distributors
12.5 Avanafil Customers

13 MARKET DYNAMICS

13.1 Avanafil Industry Trends
13.2 Avanafil Market Drivers
13.3 Avanafil Market Challenges
13.4 Avanafil Market Restraints

14 KEY FINDINGS IN THE GLOBAL AVANAFIL STUDY


15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES

Table 1. Global Avanafil Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 50 mg Avanafil
Table 3. Major Manufacturers of 100 mg Avanafil
Table 4. Major Manufacturers of 200 mg Avanafil
Table 5. Global Avanafil Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Avanafil Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Avanafil Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Avanafil Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Avanafil Revenue Market Share by Region (2018-2023)
Table 10. Global Avanafil Revenue Market Share by Region (2024-2029)
Table 11. Global Avanafil Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Avanafil Sales by Region (2018-2023) & (K MT)
Table 13. Global Avanafil Sales by Region (2024-2029) & (K MT)
Table 14. Global Avanafil Sales Market Share by Region (2018-2023)
Table 15. Global Avanafil Sales Market Share by Region (2024-2029)
Table 16. Global Avanafil Sales by Manufacturers (2018-2023) & (K MT)
Table 17. Global Avanafil Sales Share by Manufacturers (2018-2023)
Table 18. Global Avanafil Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Avanafil Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Avanafil, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Avanafil Price by Manufacturers 2018-2023 (USD/MT)
Table 22. Global Avanafil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Avanafil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avanafil as of 2022)
Table 24. Global Key Manufacturers of Avanafil, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Avanafil, Product Offered and Application
Table 26. Global Key Manufacturers of Avanafil, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Avanafil Sales by Type (2018-2023) & (K MT)
Table 29. Global Avanafil Sales by Type (2024-2029) & (K MT)
Table 30. Global Avanafil Sales Share by Type (2018-2023)
Table 31. Global Avanafil Sales Share by Type (2024-2029)
Table 32. Global Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Avanafil Revenue Share by Type (2018-2023)
Table 35. Global Avanafil Revenue Share by Type (2024-2029)
Table 36. Avanafil Price by Type (2018-2023) & (USD/MT)
Table 37. Global Avanafil Price Forecast by Type (2024-2029) & (USD/MT)
Table 38. Global Avanafil Sales by Application (2018-2023) & (K MT)
Table 39. Global Avanafil Sales by Application (2024-2029) & (K MT)
Table 40. Global Avanafil Sales Share by Application (2018-2023)
Table 41. Global Avanafil Sales Share by Application (2024-2029)
Table 42. Global Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Avanafil Revenue Share by Application (2018-2023)
Table 45. Global Avanafil Revenue Share by Application (2024-2029)
Table 46. Avanafil Price by Application (2018-2023) & (USD/MT)
Table 47. Global Avanafil Price Forecast by Application (2024-2029) & (USD/MT)
Table 48. US & Canada Avanafil Sales by Type (2018-2023) & (K MT)
Table 49. US & Canada Avanafil Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Avanafil Sales by Application (2018-2023) & (K MT)
Table 53. US & Canada Avanafil Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Avanafil Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Avanafil Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Avanafil Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Avanafil Sales by Country (2018-2023) & (K MT)
Table 60. US & Canada Avanafil Sales by Country (2024-2029) & (K MT)
Table 61. Europe Avanafil Sales by Type (2018-2023) & (K MT)
Table 62. Europe Avanafil Sales by Type (2024-2029) & (K MT)
Table 63. Europe Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Avanafil Sales by Application (2018-2023) & (K MT)
Table 66. Europe Avanafil Sales by Application (2024-2029) & (K MT)
Table 67. Europe Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Avanafil Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Avanafil Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Avanafil Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Avanafil Sales by Country (2018-2023) & (K MT)
Table 73. Europe Avanafil Sales by Country (2024-2029) & (K MT)
Table 74. China Avanafil Sales by Type (2018-2023) & (K MT)
Table 75. China Avanafil Sales by Type (2024-2029) & (K MT)
Table 76. China Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Avanafil Sales by Application (2018-2023) & (K MT)
Table 79. China Avanafil Sales by Application (2024-2029) & (K MT)
Table 80. China Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Avanafil Sales by Type (2018-2023) & (K MT)
Table 83. Asia Avanafil Sales by Type (2024-2029) & (K MT)
Table 84. Asia Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Avanafil Sales by Application (2018-2023) & (K MT)
Table 87. Asia Avanafil Sales by Application (2024-2029) & (K MT)
Table 88. Asia Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Avanafil Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Avanafil Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Avanafil Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Avanafil Sales by Region (2018-2023) & (K MT)
Table 94. Asia Avanafil Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Avanafil Sales by Type (2018-2023) & (K MT)
Table 96. Middle East, Africa and Latin America Avanafil Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Avanafil Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Avanafil Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Avanafil Sales by Application (2018-2023) & (K MT)
Table 100. Middle East, Africa and Latin America Avanafil Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Avanafil Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Avanafil Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Avanafil Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Avanafil Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Avanafil Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Avanafil Sales by Country (2018-2023) & (K MT)
Table 107. Middle East, Africa and Latin America Avanafil Sales by Country (2024-2029) & (K MT)
Table 108. VIVUS Inc Company Information
Table 109. VIVUS Inc Description and Major Businesses
Table 110. VIVUS Inc Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 111. VIVUS Inc Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. VIVUS Inc Recent Developments
Table 113. Sanofi Company Information
Table 114. Sanofi Description and Major Businesses
Table 115. Sanofi Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 116. Sanofi Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sanofi Recent Developments
Table 118. Menarini Group Company Information
Table 119. Menarini Group Description and Major Businesses
Table 120. Menarini Group Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 121. Menarini Group Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Menarini Group Recent Developments
Table 123. Auxilium Pharmaceuticals Company Information
Table 124. Auxilium Pharmaceuticals Description and Major Businesses
Table 125. Auxilium Pharmaceuticals Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 126. Auxilium Pharmaceuticals Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Auxilium Pharmaceuticals Recent Developments
Table 128. Endo International Company Information
Table 129. Endo International Description and Major Businesses
Table 130. Endo International Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 131. Endo International Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Endo International Recent Developments
Table 133. JW Pharmaceutical Company Information
Table 134. JW Pharmaceutical Description and Major Businesses
Table 135. JW Pharmaceutical Avanafil Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 136. JW Pharmaceutical Avanafil Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. JW Pharmaceutical Recent Developments
Table 138. Key Raw Materials Lists
Table 139. Raw Materials Key Suppliers Lists
Table 140. Avanafil Distributors List
Table 141. Avanafil Customers List
Table 142. Avanafil Market Trends
Table 143. Avanafil Market Drivers
Table 144. Avanafil Market Challenges
Table 145. Avanafil Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Avanafil Product Picture
Figure 2. Global Avanafil Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Avanafil Market Share by Type in 2022 & 2029
Figure 4. 50 mg Avanafil Product Picture
Figure 5. 100 mg Avanafil Product Picture
Figure 6. 200 mg Avanafil Product Picture
Figure 7. Global Avanafil Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Avanafil Market Share by Application in 2022 & 2029
Figure 9. The Young Man
Figure 10. Middle-Aged Person
Figure 11. Others
Figure 12. Avanafil Report Years Considered
Figure 13. Global Avanafil Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Avanafil Revenue 2018-2029 (US$ Million)
Figure 15. Global Avanafil Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Avanafil Revenue Market Share by Region (2018-2029)
Figure 17. Global Avanafil Sales 2018-2029 ((K MT)
Figure 18. Global Avanafil Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Avanafil Sales YoY (2018-2029) & (K MT)
Figure 20. US & Canada Avanafil Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Avanafil Sales YoY (2018-2029) & (K MT)
Figure 22. Europe Avanafil Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Avanafil Sales YoY (2018-2029) & (K MT)
Figure 24. China Avanafil Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Avanafil Sales YoY (2018-2029) & (K MT)
Figure 26. Asia (excluding China) Avanafil Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Avanafil Sales YoY (2018-2029) & (K MT)
Figure 28. Middle East, Africa and Latin America Avanafil Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Avanafil Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Avanafil in the World: Market Share by Avanafil Revenue in 2022
Figure 31. Global Avanafil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Avanafil Sales Market Share by Type (2018-2029)
Figure 33. Global Avanafil Revenue Market Share by Type (2018-2029)
Figure 34. Global Avanafil Sales Market Share by Application (2018-2029)
Figure 35. Global Avanafil Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Avanafil Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Avanafil Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Avanafil Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Avanafil Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Avanafil Revenue Share by Country (2018-2029)
Figure 41. US & Canada Avanafil Sales Share by Country (2018-2029)
Figure 42. U.S. Avanafil Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Avanafil Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Avanafil Sales Market Share by Type (2018-2029)
Figure 45. Europe Avanafil Revenue Market Share by Type (2018-2029)
Figure 46. Europe Avanafil Sales Market Share by Application (2018-2029)
Figure 47. Europe Avanafil Revenue Market Share by Application (2018-2029)
Figure 48. Europe Avanafil Revenue Share by Country (2018-2029)
Figure 49. Europe Avanafil Sales Share by Country (2018-2029)
Figure 50. Germany Avanafil Revenue (2018-2029) & (US$ Million)
Figure 51. France Avanafil Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Avanafil Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Avanafil Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Avanafil Revenue (2018-2029) & (US$ Million)
Figure 55. China Avanafil Sales Market Share by Type (2018-2029)
Figure 56. China Avanafil Revenue Market Share by Type (2018-2029)
Figure 57. China Avanafil Sales Market Share by Application (2018-2029)
Figure 58. China Avanafil Revenue Market Share by Application (2018-2029)
Figure 59. Asia Avanafil Sales Market Share by Type (2018-2029)
Figure 60. Asia Avanafil Revenue Market Share by Type (2018-2029)
Figure 61. Asia Avanafil Sales Market Share by Application (2018-2029)
Figure 62. Asia Avanafil Revenue Market Share by Application (2018-2029)
Figure 63. Asia Avanafil Revenue Share by Region (2018-2029)
Figure 64. Asia Avanafil Sales Share by Region (2018-2029)
Figure 65. Japan Avanafil Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Avanafil Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Avanafil Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Avanafil Revenue (2018-2029) & (US$ Million)
Figure 69. India Avanafil Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Avanafil Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Avanafil Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Avanafil Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Avanafil Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Avanafil Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Avanafil Sales Share by Country (2018-2029)
Figure 76. Brazil Avanafil Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Avanafil Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Avanafil Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Avanafil Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Avanafil Revenue (2018-2029) & (US$ Million)
Figure 81. Avanafil Value Chain
Figure 82. Avanafil Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed


More Publications